Echo Health Ventures
Investments
48Portfolio Exits
4Partners & Customers
3About Echo Health Ventures
Echo Health Ventures invests to build and grow tomorrow's great health care companies. The firm invests across every stage and work with our portfolio companies to challenge and transform the health care system. As a strategic collaboration of Cambia Health Solutions and Mosaic Health Solutions, it works closely with its Parents to catalyze the development of its portfolio companies and accelerate their innovations to scale nationally. Echo Health Ventures operates nationwide with offices in Durham, Portland, Seattle and Boston.
Want to inform investors similar to Echo Health Ventures about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Latest Echo Health Ventures News
Sep 18, 2023
Sempre Health – a leading solution for behavior-based healthcare pricing – recently announced $20 million in additional funding from three new investors, including Cencora Ventures and Echo Health Ventures. And existing investors including the Blue Venture Fund, UPMC Enterprises and Industry Ventures also participated. This funding comes at an important time for the millions of Americans who struggle to afford their life-saving medications. Many people have benefited from Sempre programs, which drive a more than 20% improvement in adherence and Net Promoter Score of 95, a testament to the high level of satisfaction Sempre patients have with the company’s dynamic discount and SMS-based adherence solutions. Rather than tapping into traditional coupons and cash card programs, Sempre aligns multiple healthcare stakeholders to dynamically adjust a patient’s out-of-pocket costs at the point of dispense based on individual adherence and benefit design. With the new funding round, Sempre will accelerate growth of its two-sided network of pharma manufacturers and health plans, launch products for new populations, and significantly grow the number of patients helped by the unique solution. Cencora Ventures, formerly known as AB Health Ventures (the corporate venture fund of Cencora) understands the importance of medication adherence in driving healthcare outcomes and believes Sempre’s differentiated solution can drive meaningful impact. Echo Health Ventures is a purpose-driven strategic VC and growth equity firm focused on accelerating transformational healthcare innovation on a national scale. And Echo invests to grow great healthcare companies by building strong relationships between enterprises and innovators to meet the needs of tomorrow’s healthcare consumers in an economically sustainable way. The participation of existing investors – including Blue Venture Fund, UPMC Enterprises, and Industry Ventures – further demonstrates their continued confidence in Sempre Health’s mission and growth trajectory. KEY QUOTES: “Cencora is committed to advancing innovative solutions that better enable medication access and affordability in support of patient health. Sempre’s unique business model has the ability to evolve traditional market access approaches for life sciences companies and drive substantial improvement in medication adherence.” – Leslie Donato, EVP, Chief Strategy Officer at Cencora “Echo Health Ventures invests in companies that address the complexity of healthcare head-on and deliver better health and member experiences while reducing overall costs. We look forward to partnering with Sempre to support their work to align healthcare stakeholders to improve patient health and deliver better outcomes.” – Jose Guerola, Principal at Echo Health Ventures “Since our founding, we’ve remained focused on helping people afford and take their medications as prescribed. We are excited to work with investors representing every major stakeholder in the pharmaceutical value chain, who recognize the significance of Sempre’s approach and are committed to fundamentally changing how medications are accessed in the United States.” – Anurati Mathur, CEO of Sempre Health “Echo Health Ventures invests in companies that address the complexity of healthcare head-on and deliver better health and member experiences while reducing overall costs. We look forward to partnering with Sempre to support their work to align healthcare stakeholders to improve patient health and deliver better outcomes.” – Jose Guerola, Principal at Echo Health Ventures Trending on Pulse 2.0
Echo Health Ventures Investments
48 Investments
Echo Health Ventures has made 48 investments. Their latest investment was in Sempre Health as part of their Series C on September 9, 2023.
Echo Health Ventures Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
9/13/2023 | Series C | Sempre Health | $20M | Yes | 2 | |
7/26/2023 | Series B - III | Octave Bioscience | $30M | No | 1 | |
5/31/2023 | Series C | Strive Health | $166M | No | 7 | |
4/17/2023 | Series D | |||||
1/9/2023 | Series B |
Date | 9/13/2023 | 7/26/2023 | 5/31/2023 | 4/17/2023 | 1/9/2023 |
|---|---|---|---|---|---|
Round | Series C | Series B - III | Series C | Series D | Series B |
Company | Sempre Health | Octave Bioscience | Strive Health | ||
Amount | $20M | $30M | $166M | ||
New? | Yes | No | No | ||
Co-Investors | |||||
Sources | 2 | 1 | 7 |
Echo Health Ventures Portfolio Exits
4 Portfolio Exits
Echo Health Ventures has 4 portfolio exits. Their latest portfolio exit was mPulse Mobile on January 10, 2022.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
1/10/2022 | Acq - Fin | 1 | |||
Date | 1/10/2022 | |||
|---|---|---|---|---|
Exit | Acq - Fin | |||
Companies | ||||
Valuation | ||||
Acquirer | ||||
Sources | 1 |
Echo Health Ventures Acquisitions
2 Acquisitions
Echo Health Ventures acquired 2 companies. Their latest acquisition was Cambia Health Solutions on November 16, 2016.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
|---|---|---|---|---|---|---|
11/16/2016 | Merger | 3 | ||||
11/16/2016 |
Date | 11/16/2016 | 11/16/2016 |
|---|---|---|
Investment Stage | ||
Companies | ||
Valuation | ||
Total Funding | ||
Note | Merger | |
Sources | 3 |
Echo Health Ventures Partners & Customers
3 Partners and customers
Echo Health Ventures has 3 strategic partners and customers. Echo Health Ventures recently partnered with DispatchHealth on July 7, 2021.
Date | Type | Business Partner | Country | News Snippet | Sources |
|---|---|---|---|---|---|
7/13/2021 | Partner | United States | 1 | ||
5/18/2021 | Partner | ||||
4/18/2018 | Partner |
Date | 7/13/2021 | 5/18/2021 | 4/18/2018 |
|---|---|---|---|
Type | Partner | Partner | Partner |
Business Partner | |||
Country | United States | ||
News Snippet | |||
Sources | 1 |
Echo Health Ventures Team
5 Team Members
Echo Health Ventures has 5 team members, including current Chief Executive Officer, Robert Coppedge.
Name | Work History | Title | Status |
|---|---|---|---|
Robert Coppedge | Chief Executive Officer | Current | |
Name | Robert Coppedge | ||||
|---|---|---|---|---|---|
Work History | |||||
Title | Chief Executive Officer | ||||
Status | Current |
Compare Echo Health Ventures to Competitors
LRVHealth is a venture capital firm. The firm invests in seed-stage, early-stage, and later-stage companies. It focuses on the healthcare sector. The company was formerly known as Long River Ventures. It was founded in 2000 and is based in Boston, Massachusetts.
J. Lamarck is a company that offers advisory services to private individuals, companies and pension funds who want to invest in the biotechnology sector.nThe company offers a high quality service and its analyst provide professional assistance to people who want to diversify a part of their portfolio in this emerging industry. Because of the nature of biotechnology investments, the company believe it is important that users work with specialists to define their portfolio strategy. Generally, specialists do things better.nOver the next few years the company will be witness of astonishing progress in health care and medicine, the company will be able to fight and cure diseases like AIDS and cancer finally. The company will also find solutions to clean up the environment and new crops that don't need pesticide. These new products will obviously boost the visibility of the companies that were at the beginning of this process on the stock market and consequently create great opportunity for it's shareholders.nJ. Lamarck wants to be their partner in this great venture.
Punjab Biotechnology Incubator (PBTI) welcomes users to its state-of-the- art Agri & Food Testing Laboratory set up at SAS Nagar (Mohali), the hub of Biotechnology and Information Technology in Punjab. PBTI is a State Govt. Undertaking registered as a "˜Society for Biotechnology Incubator' under the Society Registration Act 1961 and is professionally governed by Governing Council of the Society under the chairmanship of Chief Secretary, Govt. of Punjab. The day to day affairs are managed by Chief Executive Officer, supported by technical professionals of high caliber.
Laureate Pharma, Inc. is a full service contract manufacturing organization(CMO) providing development and cGMP manufacturing services in the company's FDA registered facilities in Princeton, New Jersey. The company is dedicated to supporting the development and commercialization of biopharmaceutical, drug and diagnostic products for pharmaceutical, diagnostic and biotech companies.The company aims to provide a range of product development and manufacturing services from cell line optimization and process design to development of full-scale cGMP protein production, purification and aseptic filling, in addition to corresponding testing, validation, analytical and regulatory support. The company's focus is on mammalian cell based monoclonal antibody and recombinant protein production for clinical and modest commercial supply.The company view the company's customers as partners and provide them with flexible solutions that reduce time to clinic and market. Focused on operational excellence, the company's highly experienced staff works with the company's customers to improve the quality of their products and processes.The company value the company's customers, stakeholders and associates. Therefore, the company measure the company's success by meeting the company's customers' needs, generating results in terms of quality, timeliness and on budget performance, as well as fostering an environment of trust, growth and diversity for the company's team.
Informed Medical is an interactive medical information services provider that enables biopharmaceutical companies to market directly to physicians and patients.
Blaze Systems is a provider of total LIMS software solutions for the laboratory marketplace.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.
